Renin release and the sympathetic nervous system

Drugs of Today

Volumn 36, Issue 10, 2000, Pages 699-713

  Kaul, C L ^a   Ramarao, P ^a  

^a SAS Nagar   (India)

Author keywords

[No Author keywords available]

Indexed keywords

A 74273; ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; CATECHOLAMINE DERIVATIVE; CHLOROTHIAZIDE; CYCLIC AMP; DIAZOXIDE; DOPAMINE; ETACRYNIC ACID; FUROSEMIDE; GLUCAGON; HYDRALAZINE; ISOPRENALINE; KRI 1230; LITHIUM; MINOXIDIL; N MORPHOLINOACETYL[3 (1 NAPHTHYL)ALANYL][3 (4 THIAZOLYL)ALANYL] 4 AMINO 5 CYCLOHEXYL 3 HYDROXYPENTANOIC ACID HEXYLAMIDE; NITROPRUSSIDE SODIUM; PHYSOSTIGMINE; RENIN INHIBITOR; THEOPHYLLINE; UNCLASSIFIED DRUG;

ADRENALECTOMY; ADRENERGIC SYSTEM; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; CHEMICAL SYMPATHECTOMY; DRUG EFFECT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENIN RELEASE; REVIEW;

EID: 0033653958     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2000.36.10.599209     Document Type: Review

References (137)

1. Renin in dog brain
2. Renin-like enzyme in the adrenal gland
3. A comparison of properties of renin obtained from the kidney and uterus of the rabbit
4. A renin-like substance in the placenta and uterus of the rabbit
5. A comparison of renin obtained from pregnant uterus and kidney of the dog
6. Genital tract sources of renin
7. Renal pharmacology with special emphasis on aldosterone and angiotensin
8. Handbook of Experimental Pharmacology New Series, 37
9. The renin angiotensin system
10. Renin and the kidney
11. Renin angiotensin modulation of sympathetic reflex function in essential hypertension and in the elderly
12. Effect of antihypertensive drugs on the renin-angiotensin system
13. Local renin-angiotensin system in sympathetic overactivity of spontaneously hypertensive rats
14. Measurement of renin and angiotensin (extraction and bioassay)
15. What signals the kidney to release renin?
16. The control of renin release
17. Sympathetic effect on renin secretion. Mechanism and physiological role in control of renin secretion
18. Renin and nervous system
19. Control of renin release
20. Control of renin secretion in anaesthetized dog
21. Mechanism of the effects of furosemide on renin secretion in anaesthetized dog
22. Aspects in renal physiology
23. Activation of renin in the single juxtaglomerular apparatus by sodium chloride in the tubular fluid at the macula densa
24. Effect of altered sodium concentration in the distal nephron segments on renin release
25. The physiology and pharmacology of the renal nerves
26. The functions of renal nerves
27. The pharmacological alteration of renin release
28. Sympathetic control of renin release
29. Effect of sympathetic activation on plasma renin activity in the developing rat
30. The sympathetic nervous system and renin secretion
31. The effect of α- and β-adrenergic blocking agents on the renin response to hypoglycemia and epinephrine in dogs
32. Electron microscopic and histochemical evidence for a tubular innervation in the renal cortex of the monkey
33. Effect of renal nerve stimulation, renal blood flow and adrenergic blockade on plasma renin activity in the cat
34. Effect of α and β adrenergic blocking agents on the increase in renin secretion produced by stimulation of renal nerves
35. Effect of catecholamines and renal nerve stimulation on renin release in the non-filtering kidney
36. Role of renal nerves in modulating renin release during pressure reduction at the feline kidney
37. Suppression of renin activity of hypothalamic stimulation
38. Effect of stimulation of the medulla oblongata on renin secretion in dogs
39. Renal innervation and renin activity in salt metabolism and hypertension
40. Sodium deprivation and renin secretion in unanaesthetised dog
41. Reinnervation and renin release after unilateral renal denervation in the dog
42. Renin secretion by the denervated kidney
43. Modifications of pressor response to hog renin by adrenolectomy, demedullation, adrenoceptor blocking drugs and catecholamine depletors in anaesthetized rats
44. Effects of some antihypertensive drugs and catecholamine depletors on the plasma renin activity in the rat
45. Role of sympathetic nervous system in regulating renin and aldosterone production in man
46. Effects of renal denervation on renin release in sodium depleted dogs
47. Sympathetic activation cannot fully account for increased plasma renin levels during water deprivation
48. Serotonin and stress induced increase in renin secretion are not blocked by sympathectomy/adrenal medullectomy but are blocked by β antagonists
49. Serotonergic regulation by the release of renin is not mediated by the autonomic nervous system but involves β adrenoceptors
50. Role of intracellular calcium in renal nerve mediated renin release
51. Renin release in relation to plasma noradrenaline during supine exercise in cardiac patients
52. Is the adrenergic control of renin release dominant in man?
53. Adrenergic control of renin release
54. Adrenergic regulation of renin release and effects on angiotensin and aldosterone
55. Adrenergic receptor mediation of renin secretion
56. The role of catecholamines and acetylcholine in the regulation of endocrine functions
57. Potentiation of renin release by combining renal arterial constriction and β-adrenergic stimulation
58. Stimulating action of various drugs on PRA
59. α and β Adrenergic induced renin release in man
60. The effect of chronic adrenergic receptor blockade on plasma renin activity in man
61. Different reaction of plasma renin activity after propranolol in essential and renal hypertension
62. 1-adrenoreceptors in the renin release response to graded renal sympathetic nerve stimulation
63. Effect of sympathetic stimulation and intrarenal α blockade on the secretion of renin by the human kidney
64. Adrenergic stimulation of renin secretion in the isolated perfused rat kidney
65. The inhibition of renin secretion by α-adrenergic stimulation in the isolated rat kidney
66. Increased plasma renin activity induced in rats by physostigmine and effect of α and β receptor blocking drugs thereon
67. Comparison of the effects of propranolol and ICI-66082 in blocking the renin releasing effect of renal nerve stimulation in the cat
68. Evidence for a physiological role of renal sympathetic nerves in adrenergic stimulation of renin release in the rat
69. An investigation into the type of β-adrenoreceptor mediating sympathetically activated renin release in the cat
70. The response of the adenalectomized dog to renin and other pressor agents
71. Dissociation between renin and arterial responses to β adrenergic blockade in human essential hypertension
72. Effect of catecholamines and the renal nerves on renin secretion in anaesthetized dogs
73. Effects of infusion of catecholamines and angiotensin II on renin release in anaesthetized dogs
74. Effect of cyclic AMP, sympathomimetic amines and adrenergic antagonists on renin secretion
75. Effect of hypoglycemia on plasma renin activity in dogs
76. Effect of dopamine on renin secretion in the anaesthetized dog
77. Inhibition of plasmatic renin activity by potassium
78. The influence of potassium administration and of potassium deprivation on plasma renin in normal and hypertensive subjects
79. Mechanism of action of angiotensin II and antidiuretic hormone on renin secretion
80. Functions of renin angiotensin system on isolated perfused rat kidney
81. Inhibition of renin secretion in the isolated rat kidney by antidiuretic hormone
82. Effect of diazoxide on plasma renin activity in hypertensive patients
83. Diazoxide induced renin release in man: Dissociation from plasma and extracellular fluid volume changes
84. Combined therapy with vasodilator drugs and β adrenergic blockage in hypertension
85. Renin release in patients with benign essential hypertension
86. Effect of dihydralazine on plasma renin activity and renal function during supine exercise in normal subjects
87. On the role of hydralazine in renal hemodynamics and secretion of renin
88. Adrenergic receptor mediation of renin secretion
89. A comparison of the effects of prazosin and hydralazine on blood pressure, heart rate and plasma renin activity in conscious renal hypertensive dogs
90. Differing effects of the vasodilator drugs prazosin and diazoxide on plasma renin activity in the dog
91. Hyperglycemic, antihypertensive and antidiuretic properties of Go-8288 and its comparison with diazoxide
92. Adrenergic component of renin release induced by vasodilating antihypertensive drugs in the rat
93. Control plasma renin activity and changes in sympathetic tone as determinants of minoxidil-induced increase in plasma renin activity
94. The stimulation of renin secretion of diazoxide in the isolated rat kidney
95. Acute response in plasma renin and aldosterone secretion to diuretics
96. Correlations between plasma renin, hematocrit and natriuresis
97. Reevaluation of the role of hypovolemia on the release of renin
98. Effects of mercurial diuretics and acute volume depletion on renin release in dog
99. Mechanism of the effects of furosemide on renin secretion in anesthetized dogs
100. Antagonism of hydrochlorothiazide-induced elevation in plasma renin activity by methyldopa in conscious renal hypertensive dogs
101. Renin-angiotensin aldosterone system during chronic thiazide therapy of benign hypertension
102. Angiotensin II low levels in human hypertension
103. Long term thiazide therapy in essential hypertension. Evidence for persistent alteration in plasma volume and renin activity
104. Comparison of the effects on renin release of β adrenergic antagonists with differing properties
105. β-adrenergic receptor blocking drugs, hypertension and plasma renin
106. Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases
107. Effect of practolol on blood pressure and renin release in man
108. The relationship of plasma levels of pindolol in hypertensive patients to effects on blood pressure plasma renin and plasma noradrenaline levels
109. Beta blockers and plasma renin activity in hypertension
110. Effect of methyldopa on plasma renin activity in man
111. Plasma renin and blood pressure during treatment with methyldopa
112. Effect of guanethedine and methyldopa on a standardized test for renin responsiveness
113. Renin-aldosterone system in Parkinson's disease
114. The effect of ganglionic blocking on plasma renin activity in exercising and pain stressed rats
115. Neural stimulation of release of renin
116. Plasma renin and angiotension levels in human hypertension following treatment
117. Studies on catecholamines, renin and aldosterone following Catapresan (2(2,6-dichlorphenylamine)-2-imidazoline hydrochloride) in hypertensive patients
118. Suppression of stimulated plasma renin by clonidine in the dog
119. Studies on experimental hypertension
120. Evidence against an increase in circulating pressor material in renal hypertensive rats
121. Relation of plasma renin to sodium balance and arterial pressure in experimental renal hypertension
122. Effect of renal denervation on plasma renin activity after aortic baroreceptor deafferentation
123. Control of renin release in experimental hypertension
124. Renin, sodium-retaining and sodium-excreting hormones and experimental renal hypertension
125. Renin secretion in patients with hypertension
126. Plasma renin activity and blood pressure in 89 patients receiving maintenance haemodialysis therapy
127. Essential hypertension: Renin and aldosterone, heart attack and stroke
128. Neural regulation of renin release: Experimental evidence and clinical applications in arterial hypertension
129. CGP 38560: Orally active, low-molecular-weight renin inhibitor with high potency and specificity
130. A new class of orally active glycol renin inhibitors containing phenyllactic acid at P3
131. A novel nonpeptidic, orally active renin inhibitor
132. Renin inhibitors
133. ES-8891, an orally active inhibitor of human renin
134. C-terminal modifications of nonpeptide renin inhibitors: Improved oral bioavailability via modification of physicochemical properties
135. Discovery of a well-absorbed, efficacious renin inhibitor, A-74273
136. New human renin inhibitors containing an unnatural aminoacid, norstatine
137. Ahpatinins, new acid protease inhibitors containing 4-amino-3-hydroxy-5-phenylpentatonic acid